Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In preclinical rodent research it is characterized as a cytoprotective and angiomodulatory agent, reported to influence the VEGFnitric-oxide signaling axis, modulate angiogenesis during muscle and tendon healing, and promote granulation-tissue and collagen formation at wound sites
GIP receptor agonism, the second target, is shared with tirzepatide (Mounjaro, Zepbound)
Category 2 is used for substances the agency believes may present safety risks, which means compounding pharmacies could not legally prepare those compounds for patient use
Rankings update automatically as new providers are reviewed and scores change
US$ 21.29
US$ 22.97
US$ 24.87
US$ 24.81
